Resveratrol and grape juice differentially ameliorate cardiovascular autonomic modulation in L-NAME-treated rats

Autonomic Neuroscience: Basic and Clinical

Volumn 179, Issue 1-2, 2013, Pages 9-13

  Dillenburg, Denise Ruttke ^c   Mostarda, Cristiano ^a,d   Moraes Silva, Ivana Cinthya ^a   Ferreira, Daiane ^b   Bós, Denielli da Silva Gonçalves ^b   Duarte, Ana Amélia Machado ^b   Irigoyen, Maria Cláudia ^a   Rigatto, Katya ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^d FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

Author keywords

Autonomic modulation; Grape juice; L NAME; Resveratrol

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC INNERVATION; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; GRAPE JUICE; HEART; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SYMPATHETIC INNERVATION; SYSTOLIC BLOOD PRESSURE;

AUTONOMIC MODULATION; GRAPE JUICE; L-NAME; RESVERATROL;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BEVERAGES; CARDIOVASCULAR SYSTEM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HEMODYNAMICS; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; OXIDATION-REDUCTION; RATS; RATS, WISTAR; STILBENES; VASODILATOR AGENTS; VITIS;

EID: 84897044496     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2013.06.002     Document Type: Article

References (28)

1. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981, 77:373-382.
2. Bhatt S.R., Lokhandwala M.F., Banday A.A. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur. J. Pharmacol. 2011, 667:258-264.
3. Chu L.M., Robich M.P., Lassaletta A.D., Feng J., Laham R.J., Burgess T., Clements R.T., Sellke F.W. Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia. Surgery 2011, 150:390-399.
4. Farah V.M., Moreira E.D., Pires M.D., Irigoyen M.C., Krieger E.M. Comparison of three methods for the determination of baroreflex sensitivity in conscious rats. Braz. J. Med. Biol. Res. 1999, 32:361-369.
5. Harthmann A.D., De Angelis K., Costa L.P., Senador D., Schaan B.D., Krieger E.M., Irigoyen M.C. Exercise training improves arterial baro- and chemoreflex in control and diabetic rats. Auton. Neurosci. 2007, 133:115-120.
6. Kristek F. Pentaerythrityl tetranitrate attenuates structural changes in conduit arteries evoked by long-term NO-synthase inhibition. Br. J. Pharmacol. 2000, 130(2):450-456.
7. Kunes J., Hojná S., Kadlecová M., Dobesová Z., Rauchová H., Vokurková M., Loukotová J., Pechánová O., Zicha J. Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol. Res. 2004, 53(Suppl. 1):S23-S34.
8. La Rovere M.T., Bigger J.T., Marcus F.I., Mortara A., Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998, 351:478-484.
9. Lee T.M., Chen C.C., Hsu Y.J. Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts. Free Radic. Biol. Med. 2011, 50:1461-1470.
10. Miao C.Y., Su D.F. The importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervation. J. Hypertens. 2002, 20:1865-1872.
11. Mostarda C., Rodrigues B., Vane M., Moreira E.D., Rosa K.T., Moraes-Silva I.C., Lacchini S., Casarini D.E., De Angelis K., Irigoyen M.C. Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clin. Exp. Pharmacol. Physiol. 2009, 37:447-452.
12. Mostarda C., Moraes-Silva I.C., Moreira E.D., Medeiros A., Piratello A.C., Consolim-Colombo F.M., Caldini E.G., Brum P.C., Krieger E.M., Irigoyen M.C. Baroreflex sensitivity impairment is associated with cardiac diastolic dysfunction in rats. J. Card. Fail. 2011, 17:519-525.
13. Pagani M., Somers V., Furlan R., Dell'Orto S., Conway J., Baselli G., Cerutti S., Sleight P., Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 1988, 12:600-610.
14. Park Y.K., Kim J.S., Kang M.H. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors 2004, 22:145-147.
15. Pechánová O., Bernatova I., Babal P., Martinez M.C., Kysela S., Stvrtina S., Andriantsitohaina R. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J. Hypertens. 2004, 22:1551-1559.
16. Pechánová O., Dobesová Z., Cejka J., Kunes J., Zicha J. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. J. Hypertens. 2004, 22(1):167-173.
17. Petrovski G., Gurusamy N., Das D.K. Resveratrol in cardiovascular health and disease. Ann. N. Y. Acad. Sci. 2011, 1215:22-33.
18. Romero-Pérez Al, Ibern-Goméz M., Lamuela Raventós R.M., de La Torre-Boronat M.C. Piceid, the major resveratrol derivative, in grape juice. J. Agric. Food Chem. 1999, 47(4):1533-1536.
19. Rosendorff C., Black H.R., Cannon C.P., Gersh B.J., Gore J., Izzo J.L., Kaplan N.M., O'Connor C.M., O'Gara P.T., Oparil S. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007, 115:2761-2788.
20. Schmitt C.A., Heiss E.H., Dirsch V.M. Effect of resveratrol on endothelial cell function: molecular mechanisms. Biofactors 2010, 36:342-349.
21. Soares P.P., da Nobrega A.C., Ushizima M.R., Irigoyen M.C. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton. Neurosci. 2004, 113:24-31.
22. Souza S.B., Flues K., Paulini J., Mostarda C., Rodrigues B., Souza L.E., Irigoyen M.C., De Angelis K. Role of exercise training in cardiovascular autonomic dysfunction and mortality in diabetic ovariectomized rats. Hypertension 2007, 50:786-791.
23. Spanier G., Xu H., Xia N., Tobias S., Deng S., Wojnowski L., Forstermann U., Li H. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J. Physiol. Pharmacol. 2009, 60(Suppl. 4):111-116.
24. Török J., Kristek F. Beneficial effect of pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition. Vascul. Pharmacol. 2002, 38(3):177-182.
25. WHO World Health Statistics 2009 2009, World Health Organization, Geneva.
26. Wu J.M., Wang Z.R., Hsieh T.C., Bruder J.L., Zou J.G., Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int. J. Mol. Med. 2001, 8:3-17.
27. Zhang Z.H., Yu Y., Wei S.G., Felder R.B. Centrally administered lipopolysaccharide elicits sympathetic excitation via NAD(P)H oxidase-dependent mitogen-activated protein kinase signaling. J. Hypertens. 2010, 28(4):806-816.
28. Zicha J., Dobesová Z., Kunes J. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertens. Res. 2006, 29(12):1021-1027.